Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Europe
|
US/Canada
|
Japan
|
Asia (excluding Japan)
|
Latin America
|
Rest of World
|
International - US/CANADA
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Furiex ready to progress MuDelta for IBS to Phase III
08 September 2011
Focus on Almirall: partnering, new products and mature marke...
Pops: merger will "transform" Alkermes-EDT into "fully integ...
Genzyme yet to confirm date of next Fabrazyme shipment
08 September 2011
Novartis' Votubia (everolimus) approved in Europe
08 September 2011
US court rules Acorda's Zanaflex capsules patent invalid
08 September 2011
Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
08 September 2011
>> More News...
LATEST ANALYSIS
Market Insight - Originator/generic competition: who's the 'bad guy'?
29 January 2010
Challenges and opportunities in the Philippine pharma market
08 January 2010
Risk sharing: Pharma's failure to prove its value
18 December 2009
>> More Analysis...
LATEST FEATURES
Merck BioVentures: where biosimilars make a difference
23 June 2011
Face-to-Face: Trophos - The French firm that hooked Actelion
23 July 2010
Interview: European Medicines Agency gets serious about its global strategy
03 March 2010
>> More Features...
LATEST COMMENT
Dapagliflozin: 'No' from FDA advisers could spell trouble for new diabetes class
21 July 2011
Looking at the wider impact of the Sanofi-Genzyme deal
28 February 2011
Private investment round-up: December 2009
06 January 2010
>> More Comment...
LATEST SCIENCE
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis
Pharmacotherapy of age-related macular degeneration
12 May 2009
>> More Science...
REFINE BY
COMPANY/ORGANISATION
PFIZER
NOVARTIS
GLAXOSMITHKLINE
SANOFI-AVENTIS
CONDITION
CANCER
PAIN
DIABETES
HIV
GEOGRAPHY
JAPAN
CANADA
GERMANY
INDIA
DRUG
BEVACIZUMAB
RITUXIMAB
SIMVASTATIN
INFLIXIMAB
